To date, over 100 gene, cell, and RNA therapies have received global approval, with more than 3,700 products in development. Genes account for 55% of these innovations, while cell therapies represent 53%. In this flourishing field, stability, safety, and proven efficacy are paramount in driving the continuous advancement of Cell and Gene Therapy (CGT) products.
Creative Biogene is a global biotechnology company specializing in providing biosafety testing services designed to ensure the safety and compliance of your CGT products. Our services encompass comprehensive testing solutions across the entire product lifecycle, including identity testing, potency assays, and purity assessments.
